Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibitor on renal function in cardiovascular disease patients with type 2 diabetes mellitus: a…

Overview of attention for article published in Frontiers in endocrinology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,443 followers.

RT @FrontEndocrinol: New Research: Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibit…

RT @FrontEndocrinol: New Research: Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibit…

RT @FrontEndocrinol: New Research: Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibit…

RT @FrontEndocrinol: New Research: Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibit…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.